Misdiagnosis of Leiomyosarcoma after Radiofrequency Ablation of Uterine Myomas

Shira Varon, Ram Parvataneni, L Elaine Waetjen, Kathleen Dunn, Vanessa L. Jacoby

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Minimally invasive therapies to treat symptoms of uterine myomas can be effective alternatives to major surgery. Such modalities include pharmacologic agents, uterine artery embolization, magnetic resonance–guided focused ultrasound, and laparoscopic radiofrequency ablation, known as the Acessa procedure. Acessa is used to treat women with symptomatic myomas and was approved by the US Food and Drug Administration in 2012. This case describes a patient who underwent Acessa and subsequently required hysterectomy for refractory symptoms. Pathology of her tumor was initially classified as epithelioid leiomyosarcoma but on subsequent review was classified as benign. This report highlights the challenges of accurate histologic diagnosis in the setting of using new therapeutic modalities. Clinicians should report such interventions to pathologists at the time of surgery to allow for accurate diagnosis.

Original languageEnglish (US)
JournalJournal of Minimally Invasive Gynecology
DOIs
StateAccepted/In press - Jan 1 2019

Keywords

  • Acessa
  • Leiomyosarcoma
  • Myomas
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Misdiagnosis of Leiomyosarcoma after Radiofrequency Ablation of Uterine Myomas'. Together they form a unique fingerprint.

  • Cite this